In DM, multiple signaling pathways, including epidermal growth factor receptor (EGFR)/PI3K/AKT and extracellular signal regulated kinases (ERKs), are affected and activate their downstream Bcl2-associated death signaling, increasing apoptosis and decreasing proliferation, then impeding wound healing (142). The gene discussed is EGFR; the disease is diabetes mellitus.